{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:38:08Z","timestamp":1775083088834,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>In busulfan-based conditioning regimen for hematopoietic stem cell transplantation in children, accurate a priori determination of the first dose is important because of its narrow therapeutic window. Sickle cell disease (SCD) influences pharmacokinetics of the commonly used drugs by affecting organs responsible for drug metabolism and elimination. This pharmacokinetics study assesses the influence of SCD on the metabolic pathway of busulfan that is mainly metabolized in the liver. In this retrospective cross-sectional case-control study, 16 patients with SCD were matched to 50 patients without SCD on known busulfan clearance\u2019s covariates (glutathione-S-transferase alpha1 polymorphisms, age, weight). Clearance of the first dose of busulfan was not significantly different independently of genetic or anthropometric factors in patients with or without SCD.<\/jats:p>","DOI":"10.1097\/mph.0000000000002106","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T11:29:11Z","timestamp":1614857351000},"page":"e867-e872","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let\u2019s Clear Up That Case With Some Controls"],"prefix":"10.1097","volume":"43","author":[{"given":"Amandine","family":"Remy","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology, Univ. Lille, CHU Lille, Lille, France"},{"name":"Unit\u00e9 de pharmacologie clinique"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Th\u00e9or\u00eat","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de pharmacologie clinique"},{"name":"Pharmacology and Physiology"},{"name":"Charles-Bruneau Cancer Center, CHU Sainte-Justine Research Center, Universit\u00e9 de Montr\u00e9al"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Ansari","sequence":"additional","affiliation":[{"name":"CANSEARCH Research Laboratory, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva"},{"name":"Department of Women-Children-Adolescents, Division of General Pediatrics, Pediatric Onco-Hematology Unit, Geneva University Hospital, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique","family":"Bittencourt","sequence":"additional","affiliation":[{"name":"Pediatrics"},{"name":"Charles-Bruneau Cancer Center, CHU Sainte-Justine Research Center, Universit\u00e9 de Montr\u00e9al"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Ducruet","sequence":"additional","affiliation":[{"name":"Applied Clinical Research Unit, CHU Sainte-Justine, Montreal, QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Nava","sequence":"additional","affiliation":[{"name":"CANSEARCH Research Laboratory, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva"},{"name":"Department of Women-Children-Adolescents, Division of General Pediatrics, Pediatric Onco-Hematology Unit, Geneva University Hospital, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Pastore","sequence":"additional","affiliation":[{"name":"Pediatrics"},{"name":"Charles-Bruneau Cancer Center, CHU Sainte-Justine Research Center, Universit\u00e9 de Montr\u00e9al"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Rezgui","sequence":"additional","affiliation":[{"name":"Charles-Bruneau Cancer Center, CHU Sainte-Justine Research Center, Universit\u00e9 de Montr\u00e9al"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Krajinovic","sequence":"additional","affiliation":[{"name":"Pharmacology and Physiology"},{"name":"Pediatrics"},{"name":"Charles-Bruneau Cancer Center, CHU Sainte-Justine Research Center, Universit\u00e9 de Montr\u00e9al"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niina","family":"Kleiber","sequence":"additional","affiliation":[{"name":"Pharmacology and Physiology"},{"name":"Pediatrics"},{"name":"Research Center, CHU Sainte-Justine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00694339","article-title":"Pharmacokinetics of busulfan: correlation with veno\u2010occlusive disease in patients undergoing bone marrow transplantation","volume":"25","author":"Grochow","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/pbc.25376","article-title":"New insights into the pharmacokinetics of intravenous busulfan in children with sickle cell anemia undergoing bone marrow transplantation","volume":"62","author":"Gaziev","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1182\/blood-2010-01-265405","article-title":"Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring","volume":"115","author":"Gaziev","year":"2010","journal-title":"Blood"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/bmt.2015.321","article-title":"Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem- cell transplantation in thalassemia pediatric patients","volume":"51","author":"Ansari","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"90852","DOI":"10.18632\/oncotarget.20310","article-title":"GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study","volume":"8","author":"Ansari","year":"2017","journal-title":"Oncotarget"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/bcp.13566","article-title":"Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation","volume":"84","author":"Nava","journal-title":"Br J Clin Pharmacol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V82.3.1030.1030","article-title":"Busulfan disposition below the age of three: alteration in children with lysosomal storage disease","volume":"82","author":"Vassal","year":"1993","journal-title":"Blood"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/FTD.0b013e318039b478","article-title":"Influence of underlying disease on busulfan disposition in pediatric bone marrow transplant recipients: a nonparametric population pharmacokinetic study","volume":"29","author":"Bertholle-Bonnet","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/AAC.00637-17","article-title":"Population pharmacokinetics of cefotaxime and dosage recommendations in children with sickle cell disease","volume":"62","author":"Maksoud","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ki.2012.388","article-title":"Comparison of the glomerular filtration rate in children by the new revised Schwartz formula and a new generalized formula","volume":"83","author":"Gao","year":"2013","journal-title":"Kidney Int"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0272-5231(03)00096-0","article-title":"Pharmacologic issues in the critically ill","volume":"24","author":"Krishnan","year":"2003","journal-title":"Clin Chest Med"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00467-019-04237-3","article-title":"Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study","volume":"34","author":"Zahr","year":"2019","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.ajkd.2018.12.027","article-title":"Progressive decline in estimated GFR in patients with sickle cell disease: an observational cohort study","volume":"74","author":"Derebail","year":"2019","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2215\/CJN.08511109","article-title":"Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature","volume":"5","author":"Haymann","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3476(98)70396-8","article-title":"Hepatic function as assessed by lidocaine metabolism in sickle cell disease","volume":"132","author":"Gremse","year":"1998","journal-title":"J Pediatr"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jpain.2010.10.012","article-title":"Increased clearance of morphine in sickle cell disease: implications for pain management","volume":"12","author":"Darbari","year":"2011","journal-title":"J Pain Off J Am Pain Soc"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/17425255.2017.1360277","article-title":"Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review","volume":"13","author":"Myers","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbmt.2006.08.037","article-title":"Pharmacokinetics of once-daily IV Busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule","volume":"13","author":"Madden","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/FTD.0b013e3181817428","article-title":"Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients","volume":"30","author":"Zwaveling","year":"2008","journal-title":"Ther Drug Monit"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:10:49Z","timestamp":1754338249000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002106","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"assertion":[{"value":"2020-05-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}